Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Debate over dash-27 amendment to HB 4040 exposes split between industry and patient advocates on prior authorization
Summary
Witnesses and advocates differed over HB 4040 dash-27: industry witnesses said technical implementation problems require preserving current access via the amendment; the National Alliance on Mental Illness urged rejection, saying dash-27 would undo carefully negotiated safeguards from 2021.
At a Feb. 10 hearing on House Bill 4040, proponents and opponents sparred over a late-filed dash-27 amendment that would change prior-authorization rules for certain mental health medications in Medicaid.
Anne Murray of Bristol Myers Squibb told the committee the amendment would effectively restore longstanding open-access practice after the Oregon Health Authority told…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
